{"id":"https://openalex.org/W7214066985","doi":"https://doi.org/10.3389/fonc.2026.1924010","title":"Preclinical characterization of S095029, a novel clinical-stage Fc-attenuated NKG2A-blocking antibody for cancer immunotherapy","display_name":"Preclinical characterization of S095029, a novel clinical-stage Fc-attenuated NKG2A-blocking antibody for cancer immunotherapy","publication_year":2026,"publication_date":"2026-09-23","ids":{"openalex":"https://openalex.org/W7214066985","doi":"https://doi.org/10.3389/fonc.2026.1924010","pmid":"https://pubmed.ncbi.nlm.nih.gov/42846305","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13643682"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1924010","doi":"https://doi.org/10.3389/fonc.2026.1924010","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1924010","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1924010/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1924010/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005390565","display_name":"Maria Carlsen Melander","orcid":"https://orcid.org/0009-0002-6985-1826","observed_orcids":["https://orcid.org/0009-0002-6985-1826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Carlsen Melander","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152508498","display_name":"Franziska Uhlenbrock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Franziska Uhlenbrock","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050776415","display_name":"Anne Worsaae","orcid":"https://orcid.org/0000-0001-8754-7890","observed_orcids":["https://orcid.org/0000-0001-8754-7890"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Worsaae","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5129436810","display_name":"Randi W. Hansen","orcid":"https://orcid.org/0000-0001-5547-683X","observed_orcids":["https://orcid.org/0000-0001-5547-683X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randi W. Hansen","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036542155","display_name":"Julien Mafille","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julien Mafille","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027030488","display_name":"Daniel Andersen","orcid":"https://orcid.org/0000-0002-7293-0595","observed_orcids":["https://orcid.org/0000-0002-7293-0595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Andersen","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047471999","display_name":"Samantha Knockaert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Samantha Knockaert","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114302507","display_name":"Wendy Philippon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Wendy Philippon","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044719871","display_name":"Nikolaj Dietrich","orcid":"https://orcid.org/0000-0002-3477-0922","observed_orcids":["https://orcid.org/0000-0002-3477-0922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolaj Dietrich","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152555703","display_name":"Michael M. Grandal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael M. Grandal","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029924466","display_name":"Agnete Marie Granau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnete Marie Granau","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152511329","display_name":"Chris D. Madsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris D. Madsen","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108987367","display_name":"Alba D\u00edaz Herrero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4403386645","display_name":"Institut de recherche Saint-Louis","ror":"https://ror.org/01wa61d03","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4403386645"]},{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alba Diaz-Herrero","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, INSERM U1342"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]},{"raw_affiliation_string":"Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, INSERM U1342","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4403386645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040445034","display_name":"Fabien Melchiore","orcid":"https://orcid.org/0000-0002-1141-2946","observed_orcids":["https://orcid.org/0000-0002-1141-2946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabien Melchiore","raw_affiliation_strings":["Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003516707","display_name":"Johanna Verneau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johanna Verneau","raw_affiliation_strings":["Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152530644","display_name":"Soraia Cerqueira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Soraia Cerqueira","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071152241","display_name":"Matthieu Bouaziz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthieu Bouaziz","raw_affiliation_strings":["Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058776053","display_name":"Mathieu Boucher","orcid":"https://orcid.org/0000-0003-3403-7912","observed_orcids":["https://orcid.org/0000-0003-3403-7912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mathieu Boucher","raw_affiliation_strings":["Keyrus Life Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keyrus Life Science","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152556648","display_name":"Tania K\u00f8llgaard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tania K\u00f8llgaard","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017977617","display_name":"Jamila Elhmouzi\u2010Younes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jamila Elhmouzi-Younes","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013825576","display_name":"Niels J\u00f8rgen \u00d8stergaard Skartved","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niels J\u00f8rgen Skartved","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019942359","display_name":"Pierre Tonnerre","orcid":"https://orcid.org/0000-0002-1719-9736","observed_orcids":["https://orcid.org/0000-0002-1719-9736"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4403386645","display_name":"Institut de recherche Saint-Louis","ror":"https://ror.org/01wa61d03","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4403386645"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Tonnerre","raw_affiliation_strings":["Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, INSERM U1342"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, INSERM U1342","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4403386645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104109891","display_name":"C\u00e9line Lef\u00e8bvre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9line Lefebvre","raw_affiliation_strings":["Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier de M\u00e9decine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152511669","display_name":"V\u00e9ronique Blanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V\u00e9ronique Blanc","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068897967","display_name":"Trine Lindsted","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trine Lindsted","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016127291","display_name":"Camilla Fr\u00f6lich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camilla Fr\u00f6lich","raw_affiliation_strings":["Servier Symphogen A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier Symphogen A/S","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045839713","display_name":"Bruno Laugel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268985","display_name":"Institut Servier","ror":"https://ror.org/02q6ssq97","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405268985"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Bruno Laugel","raw_affiliation_strings":["Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Servier d\u2019Innovation Th\u00e9rapeutique, Paris-Saclay R&D Center, Rue Francis Perrin","institution_ids":["https://openalex.org/I4405268985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5045839713"],"corresponding_institution_ids":["https://openalex.org/I4405268985"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62274639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1924010","last_page":"1924010"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nkg2a","display_name":"NKG2A","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7829999923706055},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.7829999923706055},{"id":"https://openalex.org/keywords/gamma-delta-t-cells","display_name":"\u03b3\u03b4 T cells","score":0.8579999804496765},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8859999775886536},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6237999796867371},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6193000078201294},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6123999953269958},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.605400025844574},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5953999757766724},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5103999972343445},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5049999952316284},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5044000148773193},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.499099999666214},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.47859999537467957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47540000081062317},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4489000141620636},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3889000117778778},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.3783000111579895},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.37560001015663147},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3513999879360199},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3443000018596649},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.32690000534057617},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.3197000026702881},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.31209999322891235},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31029999256134033},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.3050999939441681},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.2973000109195709},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2906000018119812},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.2896000146865845},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2653999924659729},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.2628999948501587},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.2603999972343445}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1924010","doi":"https://doi.org/10.3389/fonc.2026.1924010","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1924010","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1924010/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:42846305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42846305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13643682","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13643682/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:8d10c0568dae4067a8bc654e7cac2912","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8d10c0568dae4067a8bc654e7cac2912","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1924010","doi":"https://doi.org/10.3389/fonc.2026.1924010","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1924010","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1924010/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214066985.pdf","grobid_xml":"https://content.openalex.org/works/W7214066985.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1996408493","https://openalex.org/W2023279370","https://openalex.org/W2028713816","https://openalex.org/W2035774630","https://openalex.org/W2037309674","https://openalex.org/W2038832277","https://openalex.org/W2058340238","https://openalex.org/W2079482424","https://openalex.org/W2079893379","https://openalex.org/W2081561748","https://openalex.org/W2083920899","https://openalex.org/W2130401210","https://openalex.org/W2140179235","https://openalex.org/W2152989802","https://openalex.org/W2334354575","https://openalex.org/W2527905628","https://openalex.org/W2559827832","https://openalex.org/W2902856530","https://openalex.org/W2909261579","https://openalex.org/W2943614682","https://openalex.org/W2950180668","https://openalex.org/W2968536306","https://openalex.org/W2977680118","https://openalex.org/W2989616438","https://openalex.org/W3000381131","https://openalex.org/W3145734939","https://openalex.org/W3173074706","https://openalex.org/W4200000863","https://openalex.org/W4220763804","https://openalex.org/W4224283600","https://openalex.org/W4281630256","https://openalex.org/W4293102080","https://openalex.org/W4295592571","https://openalex.org/W4297088172","https://openalex.org/W4386725951","https://openalex.org/W4387494986","https://openalex.org/W4391147855","https://openalex.org/W4393086604","https://openalex.org/W4393989120","https://openalex.org/W4399709201","https://openalex.org/W4403489553","https://openalex.org/W4403990643","https://openalex.org/W4404466548","https://openalex.org/W4408190311","https://openalex.org/W4409907961","https://openalex.org/W7120088859","https://openalex.org/W7160620647"],"related_works":["https://openalex.org/W4365511795","https://openalex.org/W7160620647","https://openalex.org/W4404067444","https://openalex.org/W4403990643","https://openalex.org/W7148987288","https://openalex.org/W4404064295","https://openalex.org/W4388091434","https://openalex.org/W3083033697","https://openalex.org/W2955716298","https://openalex.org/W7118998496"],"abstract_inverted_index":{"Natural":[0],"killer":[1,148],"group":[2],"2":[3],"family":[4],"of":[5,82,131,146,187,201],"receptor":[6],"A":[7],"(NKG2A)":[8],"and":[9,60,79,111,125,143,150,161,190,231],"its":[10],"ligand":[11,38],"human":[12,89,118],"leukocyte":[13],"antigen-E":[14],"(HLA-E)":[15],"are":[16,63,216],"increasingly":[17],"recognised":[18],"as":[19],"an":[20],"important":[21],"immune":[22],"checkpoint":[23],"restraining":[24],"lymphocyte":[25],"populations":[26],"involved":[27],"in":[28,52,107,108,172,203,222,226],"cancer":[29,230],"immunity.":[30],"Recent":[31],"clinical":[32,58,199],"studies":[33,215],"investigating":[34],"dual":[35],"NKG2A/programmed":[36],"death":[37],"1":[39],"(PD-L1)":[40],"blockade":[41,114],"versus":[42],"anti-PD-L1":[43],"monotherapy":[44],"suggest":[45],"that":[46,177],"the":[47,77,128,140,184,198],"combination":[48,223],"may":[49],"be":[50],"beneficial":[51],"immunotherapy-responsive":[53],"disease":[54],"settings.":[55],"To":[56],"date,":[57],"safety":[59],"efficacy":[61],"results":[62,196],"only":[64],"available":[65],"for":[66],"a":[67,83,121,135],"single":[68,136],"NKG2A-blocking":[69,85],"monoclonal":[70],"antibody":[71,98],"(mAb).":[72],"Here,":[73],"we":[74],"report":[75],"on":[76],"generation":[78],"preclinical":[80],"characterization":[81],"novel":[84],"agent.":[86],"The":[87],"fully":[88],"Fc-attenuated":[90],"immunoglobulin":[91],"G1":[92],"mAb":[93],"S095029,":[94],"selected":[95],"via":[96],"functional":[97,112],"repertoire":[99],"screening,":[100],"was":[101],"tested":[102],"against":[103],"benchmark":[104],"clinical-stage":[105],"antibodies":[106],"vitro":[109],"binding":[110],"NKG2A/HLA-E":[113,132],"assays.":[115],"S095029":[116,138,154,178,202,221],"bound":[117],"NKG2A":[119],"with":[120,207,224],"low":[122],"nanomolar-range":[123],"affinity":[124],"efficiently":[126],"reversed":[127],"inhibitory":[129],"effects":[130],"interaction.":[133],"As":[134],"agent,":[137],"enhanced":[139],"activation,":[141],"cytotoxicity,":[142],"cytokine":[144],"secretion":[145],"natural":[147],"(NK)":[149],"\u03b3\u03b4":[151],"T":[152,192],"cells.":[153,193],"improved":[155],"NK":[156,189],"cell":[157,228],"antibody-dependent":[158],"cellular":[159],"cytotoxicity":[160],"other":[162],"effector":[163],"functions":[164],"triggered":[165],"by":[166,182],"Fc-competent":[167],"mAbs.":[168],"In":[169],"vivo":[170],"investigations":[171],"syngeneic":[173],"mouse":[174],"models":[175],"showed":[176],"inhibited":[179],"tumour":[180,205],"growth":[181],"harnessing":[183],"anti-tumour":[185],"activity":[186],"both":[188],"CD8+":[191],"Overall,":[194],"our":[195],"support":[197],"development":[200],"immuno-oncology-responsive":[204],"settings":[206],"adequate":[208],"HLA-E":[209],"expression.":[210],"Phase":[211],"1b/2":[212],"dose":[213],"escalation":[214],"currently":[217],"underway":[218],"to":[219],"evaluate":[220],"anti-PD-1":[225],"non-small":[227],"lung":[229],"gastric":[232],"cancer.":[233]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-09-24T00:00:00"}